Earendil’s AI platform lands $1.5B Genentech collaboration

In its second major collaboration announced this year, AI-focused Earendil Labs is pairing up with Roche Holding AG’s Genentech unit in a discovery deal aimed at developing bispecific antibody therapeutics in oncology.

Summary from BioWorld Articles.

Coverage 1 article · 1 outlet

1. BioWorld Articles 13h ago
   Earendil’s AI platform lands $1.5B Genentech collaboration ↗